Oncolytic virotherapy for treatment of breast cancer, including triple-negative breast cancer
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Oncolytic virotherapy for treatment of breast cancer, including triple-negative breast cancer
Authors
Keywords
-
Journal
OncoImmunology
Volume 5, Issue 2, Pages e1078057
Publisher
Informa UK Limited
Online
2015-08-28
DOI
10.1080/2162402x.2015.1078057
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Neoadjuvant, Anthracycline-Free Chemotherapy with Carboplatin and Docetaxel in Triple-Negative, Early-Stage Breast Cancer: A Multicentric Analysis of Feasibility and Rates of Pathologic Complete Response
- (2017) Peter Kern et al. CHEMOTHERAPY
- Treatment of melanoma with a serotype 5/3 chimeric oncolytic adenovirus coding for GM-CSF: Resultsin vitro, in rodents and in humans
- (2015) Simona Bramante et al. INTERNATIONAL JOURNAL OF CANCER
- Immunological data from cancer patients treated with Ad5/3 E2F Δ24 GMCSF suggests utility for tumor immunotherapy
- (2015) Otto Hemminki et al. Oncotarget
- Oncolytic adenovirus and doxorubicin-based chemotherapy results in synergistic antitumor activity against soft-tissue sarcoma
- (2014) Mikko Siurala et al. INTERNATIONAL JOURNAL OF CANCER
- Current Approaches, Challenges and Future Directions for Monitoring Treatment Response in Prostate Cancer
- (2014) T.J. Wallace et al. Journal of Cancer
- Antiviral and Antitumor T-cell Immunity in Patients Treated with GM-CSF-Coding Oncolytic Adenovirus
- (2013) A. Kanerva et al. CLINICAL CANCER RESEARCH
- Oncolytic Virotherapy Trials--Letter
- (2013) A. Hemminki et al. CLINICAL CANCER RESEARCH
- Low-dose metronomic chemotherapy: A systematic literature analysis
- (2013) K. Lien et al. EUROPEAN JOURNAL OF CANCER
- [18F]-Fluorodeoxyglucose Positron Emission Tomography and Computed Tomography in Response Evaluation of Oncolytic Adenovirus Treatments of Patients with Advanced Cancer
- (2013) Anniina Koski et al. HUMAN GENE THERAPY
- Serotype chimeric oncolytic adenovirus coding for GM-CSF for treatment of sarcoma in rodents and humans
- (2013) Simona Bramante et al. INTERNATIONAL JOURNAL OF CANCER
- Oncolytic Adenovirus With Temozolomide Induces Autophagy and Antitumor Immune Responses in Cancer Patients
- (2013) Ilkka Liikanen et al. MOLECULAR THERAPY
- Low-dose metronomic chemotherapy: from past experience to new paradigms in the treatment of cancer
- (2012) David Loven et al. DRUG DISCOVERY TODAY
- Treatment of Chemotherapy-Refractory Cancer in the Advanced Therapy Access Program
- (2012) Akseli Hemminki MOLECULAR THERAPY
- Ad3-hTERT-E1A, a Fully Serotype 3 Oncolytic Adenovirus, in Patients With Chemotherapy Refractory Cancer
- (2012) Otto Hemminki et al. MOLECULAR THERAPY
- Enhanced anti-tumor and anti-angiogenic effects of metronomic cyclophosphamide combined with Endostar in a xenograft model of human lung cancer
- (2012) RUI WANG et al. ONCOLOGY REPORTS
- Metronomic cyclophosphamide treatment in metastasized breast cancer patients: immunological effects and clinical outcome
- (2011) Yingzi Ge et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Integrin targeted oncolytic adenoviruses Ad5-D24-RGD and Ad5-RGD-D24-GMCSF for treatment of patients with advanced chemotherapy refractory solid tumors
- (2011) Sari Pesonen et al. INTERNATIONAL JOURNAL OF CANCER
- Immunological Effects of Low-dose Cyclophosphamide in Cancer Patients Treated With Oncolytic Adenovirus
- (2011) Vincenzo Cerullo et al. MOLECULAR THERAPY
- Verapamil Results in Increased Blood Levels of Oncolytic Adenovirus in Treatment of Patients With Advanced Cancer
- (2011) Anniina Koski et al. MOLECULAR THERAPY
- Oncolytic Adenovirus Coding for Granulocyte Macrophage Colony-Stimulating Factor Induces Antitumoral Immunity in Cancer Patients
- (2010) Vincenzo Cerullo et al. CANCER RESEARCH
- Oncolytic Adenovirus ICOVIR-7 in Patients with Advanced and Refractory Solid Tumors
- (2010) P. Nokisalmi et al. CLINICAL CANCER RESEARCH
- Microarray-Based Gene Expression Profiling for Molecular Classification of Breast Cancer and Identification of New Targets for Therapy
- (2010) Rupninder Sandhu et al. Labmedicine
- Treatment of Cancer Patients With a Serotype 5/3 Chimeric Oncolytic Adenovirus Expressing GMCSF
- (2010) Anniina Koski et al. MOLECULAR THERAPY
- Metronomic chemotherapy: new rationale for new directions
- (2010) Eddy Pasquier et al. Nature Reviews Clinical Oncology
- Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria
- (2009) J. D. Wolchok et al. CLINICAL CANCER RESEARCH
- A modified E2F-1 promoter improves the efficacy to toxicity ratio of oncolytic adenoviruses
- (2009) J J Rojas et al. GENE THERAPY
- Intelligent Design: Combination Therapy With Oncolytic Viruses
- (2009) Kathryn Ottolino-Perry et al. MOLECULAR THERAPY
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search